vs

Side-by-side financial comparison of Knowles Corp (KN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $153.1M, roughly 1.3× Knowles Corp). REPLIGEN CORP runs the higher net margin — 6.7% vs 6.3%, a 0.4% gap on every dollar of revenue. On growth, Knowles Corp posted the faster year-over-year revenue change (22.7% vs 13.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-3.1M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -13.5%).

Knowles Corporation is a global leading designer and manufacturer of advanced micro-acoustic, audio processing, and precision component solutions. It serves core segments including consumer electronics, automotive, medical technology, and industrial markets, offering products such as MEMS microphones, hearing aid components, and edge audio processing ICs to worldwide clients.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

KN vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$153.1M
KN
Growing faster (revenue YoY)
KN
KN
+9.0% gap
KN
22.7%
13.6%
RGEN
Higher net margin
RGEN
RGEN
0.4% more per $
RGEN
6.7%
6.3%
KN
More free cash flow
RGEN
RGEN
$20.7M more FCF
RGEN
$17.6M
$-3.1M
KN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-13.5%
KN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
KN
KN
RGEN
RGEN
Revenue
$153.1M
$197.9M
Net Profit
$9.7M
$13.3M
Gross Margin
43.8%
52.5%
Operating Margin
10.4%
9.0%
Net Margin
6.3%
6.7%
Revenue YoY
22.7%
13.6%
Net Profit YoY
585.0%
143.9%
EPS (diluted)
$0.13
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KN
KN
RGEN
RGEN
Q1 26
$153.1M
Q4 25
$162.2M
$197.9M
Q3 25
$152.9M
$188.8M
Q2 25
$145.9M
$182.4M
Q1 25
$132.2M
$169.2M
Q4 24
$142.5M
$174.1M
Q3 24
$142.5M
$154.9M
Q2 24
$204.7M
$154.1M
Net Profit
KN
KN
RGEN
RGEN
Q1 26
$9.7M
Q4 25
$21.0M
$13.3M
Q3 25
$17.4M
$14.9M
Q2 25
$7.8M
$14.9M
Q1 25
$-2.0M
$5.8M
Q4 24
$18.5M
$-30.3M
Q3 24
$500.0K
$-654.0K
Q2 24
$-259.3M
$3.3M
Gross Margin
KN
KN
RGEN
RGEN
Q1 26
43.8%
Q4 25
44.7%
52.5%
Q3 25
45.7%
53.2%
Q2 25
41.5%
50.0%
Q1 25
40.3%
53.6%
Q4 24
42.7%
26.1%
Q3 24
44.1%
50.0%
Q2 24
28.2%
49.8%
Operating Margin
KN
KN
RGEN
RGEN
Q1 26
10.4%
Q4 25
15.9%
9.0%
Q3 25
16.9%
8.9%
Q2 25
10.1%
7.6%
Q1 25
3.0%
3.9%
Q4 24
10.8%
-17.7%
Q3 24
13.1%
-5.1%
Q2 24
6.2%
1.0%
Net Margin
KN
KN
RGEN
RGEN
Q1 26
6.3%
Q4 25
12.9%
6.7%
Q3 25
11.4%
7.9%
Q2 25
5.3%
8.2%
Q1 25
-1.5%
3.4%
Q4 24
13.0%
-17.4%
Q3 24
0.4%
-0.4%
Q2 24
-126.7%
2.2%
EPS (diluted)
KN
KN
RGEN
RGEN
Q1 26
$0.13
Q4 25
$0.23
$0.24
Q3 25
$0.20
$0.26
Q2 25
$0.09
$0.26
Q1 25
$-0.02
$0.10
Q4 24
$0.20
$-0.55
Q3 24
$0.01
$-0.01
Q2 24
$-2.88
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KN
KN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$41.0M
$767.6M
Total DebtLower is stronger
$131.0M
$542.2M
Stockholders' EquityBook value
$780.2M
$2.1B
Total Assets
$1.1B
$2.9B
Debt / EquityLower = less leverage
0.17×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KN
KN
RGEN
RGEN
Q1 26
$41.0M
Q4 25
$54.2M
$767.6M
Q3 25
$92.5M
$748.7M
Q2 25
$103.2M
$708.9M
Q1 25
$101.9M
$697.2M
Q4 24
$130.1M
$757.4M
Q3 24
$92.6M
$784.0M
Q2 24
$84.0M
$809.1M
Total Debt
KN
KN
RGEN
RGEN
Q1 26
$131.0M
Q4 25
$114.0M
$542.2M
Q3 25
$176.3M
$537.9M
Q2 25
$190.0M
Q1 25
$188.8M
Q4 24
$202.5M
$525.6M
Q3 24
$225.0M
Q2 24
$261.2M
Stockholders' Equity
KN
KN
RGEN
RGEN
Q1 26
$780.2M
Q4 25
$775.8M
$2.1B
Q3 25
$751.8M
$2.1B
Q2 25
$746.1M
$2.1B
Q1 25
$755.8M
$2.0B
Q4 24
$756.0M
$2.0B
Q3 24
$777.4M
$2.0B
Q2 24
$753.0M
$2.0B
Total Assets
KN
KN
RGEN
RGEN
Q1 26
$1.1B
Q4 25
$1.1B
$2.9B
Q3 25
$1.1B
$2.9B
Q2 25
$1.1B
$2.9B
Q1 25
$1.1B
$2.9B
Q4 24
$1.1B
$2.8B
Q3 24
$1.2B
$2.8B
Q2 24
$1.2B
$2.9B
Debt / Equity
KN
KN
RGEN
RGEN
Q1 26
0.17×
Q4 25
0.15×
0.26×
Q3 25
0.23×
0.26×
Q2 25
0.25×
Q1 25
0.25×
Q4 24
0.27×
0.27×
Q3 24
0.29×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KN
KN
RGEN
RGEN
Operating Cash FlowLast quarter
$0
$25.7M
Free Cash FlowOCF − Capex
$-3.1M
$17.6M
FCF MarginFCF / Revenue
-2.0%
8.9%
Capex IntensityCapex / Revenue
7.1%
4.1%
Cash ConversionOCF / Net Profit
0.00×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KN
KN
RGEN
RGEN
Q1 26
$0
Q4 25
$25.7M
Q3 25
$29.1M
$48.1M
Q2 25
$36.4M
$28.6M
Q1 25
$1.3M
$15.0M
Q4 24
$39.2M
Q3 24
$52.8M
$49.3M
Q2 24
$24.9M
$42.2M
Free Cash Flow
KN
KN
RGEN
RGEN
Q1 26
$-3.1M
Q4 25
$17.6M
Q3 25
$21.4M
$43.4M
Q2 25
$31.3M
$21.5M
Q1 25
$-2.7M
$11.4M
Q4 24
$33.6M
Q3 24
$49.1M
$42.3M
Q2 24
$21.7M
$37.4M
FCF Margin
KN
KN
RGEN
RGEN
Q1 26
-2.0%
Q4 25
8.9%
Q3 25
14.0%
23.0%
Q2 25
21.5%
11.8%
Q1 25
-2.0%
6.8%
Q4 24
19.3%
Q3 24
34.5%
27.3%
Q2 24
10.6%
24.3%
Capex Intensity
KN
KN
RGEN
RGEN
Q1 26
7.1%
Q4 25
9.4%
4.1%
Q3 25
5.0%
2.5%
Q2 25
3.5%
3.9%
Q1 25
3.0%
2.1%
Q4 24
2.3%
3.2%
Q3 24
2.6%
4.5%
Q2 24
1.6%
3.1%
Cash Conversion
KN
KN
RGEN
RGEN
Q1 26
0.00×
Q4 25
1.93×
Q3 25
1.67×
3.23×
Q2 25
4.67×
1.92×
Q1 25
2.57×
Q4 24
Q3 24
105.60×
Q2 24
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons